GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Concord Biotech Ltd

Concord Biotech Ltd Board Meeting to Approve Q1 FY27 Financial Results

BOARD ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 28 Jul 2026, 07:35 PM IST  ·  BSE ID: 407f3e20-c179-4ba6-8241-e361fff8816e
View Original BSE Filing (PDF)
💡
In Simple Terms
Concord Biotech's directors will meet to approve their latest financial earnings report for the first three months of the fiscal year.
🤖 AI Summary
  • Board meeting scheduled for July 31, 2026, to approve unaudited financial results.
  • Covers standalone and consolidated financial statements for Q1 FY27.
  • Limited review report from statutory auditors will also be considered.
  • Trading window closure extended up to 48 hours post-results announcement.
🏢 How This Affects the Company
💰
Financial Impact
The Board's approval of the unaudited financial results will provide clarity on the company's financial performance for the first quarter of fiscal year 2027.
⚠️
Risk Impact
The continuation of the trading window closure prevents insider trading, aligning with SEBI regulations.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders. Monitor the company's announcement of the financial results.
👤
Who Is Affected
All shareholders of Concord Biotech Limited will be affected by the information contained within the announced financial results.
🔍
Management Signal
The scheduling of the board meeting signals management's adherence to regulatory timelines for financial reporting and transparency.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board meeting on July 31, 2026, for Q1 FY27 results
Announcement of unaudited financial results
Closure of trading window post-announcement
LOW RISK Routine disclosure regarding upcoming financial results announcement.
💡 Investor Takeaway
Concord Biotech Ltd will announce its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, on July 31, 2026. The trading window remains closed.
❓ Frequently Asked Questions
When will Concord Biotech Ltd announce its Q1 FY27 financial results?
Concord Biotech Ltd's Board of Directors will consider and approve the unaudited financial results for the first quarter ended June 30, 2026, on July 31, 2026.
What period do the upcoming Concord Biotech Ltd financial results cover?
The upcoming financial results for Concord Biotech Ltd will cover the first quarter ended on June 30, 2026.
When will the trading window for Concord Biotech Ltd securities reopen?
The trading window for Concord Biotech Ltd securities will remain closed up to 48 hours after the declaration of the financial results for the first quarter ended on June 30, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.